Felkai Chelsea, Carew Jamie-Lee, Newby David, Croft Hayley
School of Biomedical Sciences and Pharmacy, College of Health Medicine and Wellbeing, The University of Newcastle, Callaghan, New South Wales, Australia.
J Intellect Disabil Res. 2025 Jul;69(7):613-620. doi: 10.1111/jir.13243. Epub 2025 Apr 24.
People with intellectual disability (ID) are more susceptible to experiencing minor health issues. This research describes the common ailments and nonprescription medications found in people with ID who have had a medication review performed by a credentialed pharmacist in Australia.
The aims of this research were to (i) describe the common ailments found within people with ID and (ii) identify and quantify the nonprescription medications documented in medication reviews for people with ID.
This research conducted a retrospective analysis of medication review reports and referrals from credentialed pharmacists who have performed a medication review for a person with ID between January 2020 and January 2024.
A total of 80 responses and reports were obtained. The average age of the person with ID was 52 years. On average, each medication review listed 6.6 common ailments and 8.0 nonprescription medications. The highest number of nonprescription medications listed for a single individual was 26.
This research is the first to exclusively examine common ailments and nonprescription medications found in people with ID through medication reviews. Further research is needed to confirm study findings revealing a potentially high occurrence of common ailments and nonprescription medication use in this population compared to other similar populations and notable polypharmacy for nonprescription medications.
智力残疾(ID)患者更容易出现轻微健康问题。本研究描述了在澳大利亚接受过有资质药剂师进行药物审查的ID患者中发现的常见疾病和非处方药物。
本研究的目的是(i)描述ID患者中发现的常见疾病,以及(ii)识别并量化ID患者药物审查中记录的非处方药物。
本研究对2020年1月至2024年1月期间为ID患者进行过药物审查的有资质药剂师的药物审查报告和转诊进行了回顾性分析。
共获得80份回复和报告。ID患者的平均年龄为52岁。平均而言,每份药物审查列出了6.6种常见疾病和8.0种非处方药物。单个个体列出的非处方药物数量最多为26种。
本研究首次通过药物审查专门研究了ID患者中发现的常见疾病和非处方药物。需要进一步的研究来证实研究结果,即与其他类似人群相比,该人群中常见疾病和非处方药物使用的发生率可能较高,且非处方药物存在明显的多药联用情况。